sur Santen Pharmaceutical Co., Ltd. (ETR:SZD)
Santen Aligns with Global Summit for Eye Health as Key Partner
Santen Pharmaceutical Co., Ltd. has announced its partnership with the inaugural Global Summit for Eye Health as a High Impact Partner. The Summit, organized by the International Agency for the Prevention of Blindness (IAPB), in collaboration with the World Health Organization (WHO), will convene in Antigua & Barbuda on November 2, 2026. The event aims to address critical gaps in global eye care by launching the Global Eye Health Compact, a framework designed to foster measurable commitments from governments and organizations worldwide.
Santen will unveil its strategic commitments to enhance global eye health, focusing on access to care and policy advancement. With over a billion people affected by preventable vision impairments globally, this initiative underscores Santen's ongoing dedication to eye health, in collaboration with various stakeholders including healthcare professionals, governments, and patient organizations. Santen's leadership aims to cultivate significant improvements in eye care delivery systems worldwide.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Santen Pharmaceutical Co., Ltd.